Inserm UMR1231, Université Bourgogne Franche-Comté, Dijon, France.
LipSTIC LabEx, Dijon, France.
Sci Rep. 2020 Sep 30;10(1):16187. doi: 10.1038/s41598-020-73020-4.
Using a MLL-AF9 knock-in mouse model, we discovered that consumption of a high-fat diet (HFD) accelerates the risk of developing acute myeloid leukemia (AML). This regimen increases the clusterization of FLT3 within lipid rafts on the cell surface of primitive hematopoietic cells, which overactivates this receptor as well as the downstream JAK/STAT signaling known to enhance the transformation of MLL-AF9 knock-in cells. Treatment of mice on a HFD with Quizartinib, a potent inhibitor of FLT3 phosphorylation, inhibits the JAK3/STAT3, signaling and finally antagonizes the accelerated development of AML that occurred following the HFD regimen. We can therefore conclude that, on a mouse model of AML, a HFD enforces the FLT3 signaling pathway on primitive hematopoietic cells and, in turn, improves the oncogenic transformation of MLL-AF9 knock-in cells and the leukemia initiation.
使用 MLL-AF9 基因敲入小鼠模型,我们发现高脂肪饮食(HFD)会加速急性髓系白血病(AML)的发病风险。该方案增加了原始造血细胞表面脂筏中 FLT3 的聚集,从而过度激活该受体以及下游 JAK/STAT 信号通路,已知该信号通路可增强 MLL-AF9 基因敲入细胞的转化。用 FLT3 磷酸化的强效抑制剂 Quizartinib 治疗 HFD 小鼠,可抑制 JAK3/STAT3 信号通路,最终拮抗 HFD 方案后 AML 的加速发展。因此,我们可以得出结论,在 AML 的小鼠模型中,HFD 会对原始造血细胞施加 FLT3 信号通路,从而促进 MLL-AF9 基因敲入细胞的致癌转化和白血病的发生。